Source link : https://www.newshealth.biz/health-news/biomarker-selected-treatment-shows-promise-for-bladder-preservation-in-mibc/
Biomarker-driven treatment for muscle-invasive bladder cancer (MIBC) led to a 2-year metastasis-free survival (MFS) rate that exceeded 70% in a phase II study, but failed to meet prespecified statistical constraints for a positive trial. Median MFS was 72.9% for 70 patients, but the lower range of the confidence the intervals for that value was 62.8% […]
Author : News Health
Publish date : 2024-12-23 21:43:55
Copyright for syndicated content belongs to the linked Source.